Featured Posts
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs,…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager…
Search Posts
Op-Eds
ObamaCare vastly expands IRS red tape
“Billions of more documents” will be have to be filled out by small businesses for the IRS so that a “spendthrift Congress can shake…
Newsletter
Wall Street Reform, GM Tomatoes and Chemical Regulation
Obama is gives a speech today in New York on the need to reform Wall Street. The Wall Street Journal reports on the debate over…
Newsletter
Unions, New Taxes and GM Crops
Andy Stern is leaving his post as head of the Service Employees International Union. The Obama Administration may soon propose a Value Added Tax (VAT).
Newsletter
Liquor Licensing, Off-label Drugs and Fannie & Freddie
A new proposal in New York to set up a “medallion” system of liquor-licensing will serve as a compromise between wine retailers and grocery store…
News Release
New Study Shows Benefits of “Off-Label” Promotion for Patients, Doctors
New Study Shows Benefits of “Off-Label” Promotion for Patients, Doctors Court to Weigh In on Pharmaceutical Free Speech Washington, D.C.,…
Study
Truth or Consequences
The Benefits of Off-Label Drug and Device Promotion…